Iniparib Plus Gemcitabine and Carboplatin in Patients With Recurrent Ovarian Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Oncologist
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Phase II Trials of Iniparib (BSI-201) in Combination with Gemcitabine and Carboplatin in Patients with Recurrent Ovarian Cancer
Oncologist 2023 Jan 30;[EPub Ahead of Print], RT Penson, AJ Ambrosio, CA Whalen, CN Krasner, PA Konstantinopoulos, C Bradley, UA Matulonis, MJ BirrerFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.